Search

Search Constraints

You searched for: Author/Creator Lin, Wanli

Search Results

2. Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC‐ESCC2019): A multicenter, phase 2 study. Issue 1 (21st March 2022)